PD 0332991 and Cetuximab in Patients With Incurable SCCHN
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
Regorafenib and Cetuximab in Patients With Advanced Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Cancer of the Head and Neck
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
CetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck
- Status
- TERMINATED
- Phase
- PHASE4
Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)
- Status
- WITHDRAWN
- Phase
- PHASE2
Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer.
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy Study of Neratinib and Cetuximab to Treat Patients With Quadruple Wild-Type Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Ipilimumab, Cetuximab, and Intensity-Modulated Radiation Therapy in Treating Patients With Previously Untreated Stage III-IVB Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Dual Targeting of EGFR With Cetuximab and Afatinib to Treat Refractory wtKRAS Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events in HPV+ OPSCC
- Status
- UNKNOWN
- Phase
- PHASE3
Nordic 8 - A Phase II Trial
- Status
- COMPLETED
- Phase
- PHASE2
Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases
- Status
- COMPLETED
- Phase
- PHASE2